Prostate cancer after exogenous testosterone treatment for impotence.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Journal of Urology

• Publication date

  1997-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0022-5347(01)64881-XPMID 9112543
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Re: Oral androgens in the treatment of hypogonadal impotent men.

  1995cited by this paper
• Oral androgens in the treatment of hypogonadal impotent men.

  1994cited by this paper
• Hypogonadal impotence treated by transdermal testosterone.

  1991cited by this paper
• Testosterone replacement with transdermal therapeutic systems. Physiological serum testosterone and elevated dihydrotestosterone levels.

  1989cited by this paper
• Prostatic complications of testosterone replacement therapy.

  1989cited by this paper

• Testosterone Therapy and Prostate Cancer: Incorporating Low-Level Evidence into Practical Recommendations.

  2022cites this paper
• Testosterone and prostate health: Have the paradigms truly shifted?

  2020cites this paper
• Testosterona replacement therapy and prostate cancer: the collapse of a paradigm?

  2015cites this paper
• Testosterone therapy and prostate cancer—safety concerns are well founded

  2015cites this paper
• [Testosterone replacement therapy and prostate cancer: the downfall of a paradigm?].

  2015cites this paper
• Serum Testosterone Level, Testosterone Replacement Treatment, and Prostate Cancer

  2013cites this paper
• Testosterone Therapy, Prostate Safety, and Other Safety Issues

  2013cites this paper
• Vitex agnus-castus essential oil affects thyroid C cells and bone metabolism in middle-aged male rats

  2013cites this paper
• AGNUS-CASTUS ESSENTIAL OIL AFFECTS THYROID C CELLS AND BONE METABOLISM IN

  2013cites this paper
• The Phytoestrogens, Calcitonin and Thyroid Hormones: Effects on Bone Tissue

  2012cites this paper
• Dynamics of Prostate-Specific Antigen Levels During Treatment with Testosterone Undecanoate in Patients with Type 2 Diabetes Mellitus

  2012cites this paper
• Soybean Phytoestrogens – Friends or Foes?

  2011cites this paper
• Use of Testosterone Replacement Therapy in Patients with Prostate Cancer

  2011cites this paper
• Differing levels of testosterone and the prostate: a physiological interplay

  2011cites this paper
• The Role of Testosterone in the Etiology and Treatment of Obesity, the Metabolic Syndrome, and Diabetes Mellitus Type 2

  2010cites this paper
• Androgens and male aging: Current evidence of safety and efficacy.

  2010cites this paper
• A safety study of administration of parenteral testosterone undecanoate to elderly men over minimally 24 months

  2010cites this paper
• Câncer de próstata e testosterona: riscos e controvérsias Prostate carcinoma and testosterone: risks and controversies

  2009cites this paper
• Testosterone therapy and prostate carcinoma

  2009cites this paper
• The benefits and risks of testosterone replacement therapy: a review

  2009cites this paper
• Testosterone and prostate cancer: revisiting old paradigms.

  2009cites this paper
• [Prostate carcinoma and testosterone: risks and controversies].

  2009influential citation
• Testosterone therapy in hypogonadal men and potential prostate cancer risk: a systematic review

  2009cites this paper
• State of the Art Reviews: Male Menopause: Fact or Fiction?

  2008cites this paper
• Androgen replacement in men undergoing treatment for prostate cancer.

  2008cites this paper
• Clinical Practice Manual for Late‐onset Hypogonadism Syndrome

  2008cites this paper
• Herbal/Hormonal Dietary Supplement Possibly Associated with Prostate Cancer Progression

  2008cites this paper
• Current and future testosterone delivery systems for treatment of the hypogonadal male

  2008cites this paper
• Testosterone replacement therapy and prostate cancer.

  2007cites this paper
• Recent trends in the treatment of testosterone deficiency syndrome

  2007cites this paper
• PROSTATE CANCER FOLLOWING TESTOSTERONE REPLACEMENT IN KLINEFELTER SYNDROME

  2007cites this paper
• Serum Testosterone: A Potentially Adjunct Screening Test for the Assessment of the Risk of Prostate Cancer Among Men with Modestly Elevated PSA Values (≥3.0 and <10.0 ng/ml)

  2006cites this paper
• Influence of demographic factors and biochemical characteristics on the prostate-specific antigen (PSA) response to testosterone replacement therapy

  2006cites this paper
• Testosterone replacement therapy and prostate risks: where's the beef?

  2006cites this paper
• Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial.

  2006cites this paper
• A rational approach to androgen therapy for hypogonadal men with prostate cancer

  2006cites this paper
• Serum testosterone: A potentially adjunct screening test for the assessment of the risk of prostate cancer among men with modestly elevated PSA values (> or =3.0 and <10.0 ng/ml).

  2006cites this paper
• Prostate cancer in men using testosterone supplementation.

  2005cites this paper
• Androgen deficiency in the etiology and treatment of erectile dysfunction.

  2005cites this paper
• Testosterone replacement therapy after primary treatment for prostate cancer.

  2005cites this paper
• The good, the bad, and the unknown of late onset hypogonadism: the urological perspective

  2005cites this paper
• ISA, ISSAM and EAU recommendations for the investigation, treatment and monitoring of late-onset hypogonadism in males: Scientific background and rationale

  2005cites this paper
• [Androgens and prostate: basic research and clinical data].

  2004cites this paper
• Androgen replacement after curative radical prostatectomy for prostate cancer in hypogonadal men.

  2004cites this paper
• Erectile dysfunction.

  2004cites this paper
• Review article Testosterone therapy in the ageing male: what about the prostate?

  2004cites this paper
• The effect of androgen supplementation therapy on the prostate

  2003cites this paper
• Prostate cancer in Klinefelter syndrome during hormonal replacement therapy.

  2003cites this paper
• Prostate-specific antigen changes in hypogonadal men treated with testosterone replacement.

  2002cites this paper
• Male sexual function and its disorders: physiology, pathophysiology, clinical investigation, and treatment.

  2001cites this paper
• Androgénothérapie: Quels sont les risques?

  2001cites this paper
• Andropause, androgen therapy and prostate safety

  1999cites this paper
• Dramatic rise in prostate-specific antigen after androgen replacement in a hypogonadal man with occult adenocarcinoma of the prostate.

  1999cites this paper